Elute
Manufacturing · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
417 S Wakara Way Ste 3510, Salt Lake Cit...Phone Number
(801) 696-4716Website
www.elutinc.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Elute
Elute, Inc. is a clinical-stage company specializing in the development of patented drug-eluting devices aimed at addressing unmet clinical needs, particularly in orthopedic infections. Their flagship product, BonVie+, is a resorbable bone graft substitute that supports natural bone restoration while delivering local antibiotics to treat periprosthetic joint infections. The company focuses on creating innovative solutions that enable patients to lead active and fulfilling lives. Elute has formed a strategic partnership with Spartan Medical to enhance their offerings in the field of bone void fillers.Explore more
Elute Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elute your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Elute had a recent Job posting/layoffs
Check out if Elute is spiking on competitors!
Product Launch: Get notified when Elute launches new products
Funding: Get notified immidiatlly once Elute has new funding data
Website visits: Recent activity has been detected on your website
Check if Elute has recently received funding, and reach out quickly before it becomes old news!
Elute, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Elute recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Elute
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Elute
Compare insights from companies similar to Elute, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elute is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Elute is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Elute.
Elute Tech Stack
A closer look at the technologies used by Elute
See more technologies
Elute News & Media
Frontier IP Group’s Elute Intelligence launches Patent Reader product to user group
Frontier IP Group PLC’s (LON:FIPP) portfolio firm, Elute Intelligence, has opened up access to its Patent Reader platform to a user group of experienced patent professionals to help them effectively and efficiently find relevant patent information. The group includes users from patent rich multinationals, high-tech SMEs and professional IP services providers, Elute said in its announcement, adding that its software tools will enable them to intelligently search patent information and identify doElute Receives Notification of Issuance of Key Patent From the US Patent & Trademark Office
SALT LAKE CITY, Jan. 31, 2018 /PRNewswire/ -- Elute, Inc., an emerging leader in developing a new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections, announced today that the Company has received a notice of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elute
Sign Up For FreeTo access detailed company insights
Elute, Inc. is a clinical-stage company specializing in the development of patented drug-eluting devices aimed at addressing unmet clinical needs, particularly in orthopedic infections. Their flagship product, BonVie+, is a resorbable bone graft substitute that supports natural bone restoration while delivering local antibiotics to treat periprosth... Read More
